Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Artificial intelligence-based personalized and interactive radiotherapy target definition for enhanced cancer care

Project description

Advancing personalised radiotherapy with AI

Radiotherapy is a key treatment for cancer, but defining the areas to target with radiation is predominantly done manually. This creates variations in quality between hospitals and can affect patient outcomes. While AI already helps standardise the mapping of healthy organs, designing personalised target volumes for each patient remains a major challenge. A solution could make cancer care more precise, efficient and consistent. In this context, the ERC-funded AI-PIONEER project will combine large language models with 3D image segmentation. Using a language-based interface, it will integrate scientific knowledge and patient data to create tailored treatment plans. The goal is to significantly reduce the burden on clinicians while elevating the quality of cancer care.

Objective

Cancer is the second leading cause of death globally, with radiotherapy (RT) being a cornerstone treatment for nearly half of all patients. A key element of RT is the accurate definition of target volumes, a task traditionally performed manually by physicians. The quality of target volumes differs significantly between treatment centers and healthcare systems, directly impacting patients’ outcomes. While advances in artificial intelligence (AI) have simplified and standardized the segmentation of healthy organs, creating personalized target volumes that incorporate individual patient-specific data remains an unsolved challenge.

AI-PIONEER aims to revolutionize the RT treatment planning process by combining the vast potential of multimodal large language models with 3D image segmentation. For the first time, AI-PIONEER will provide a language-based interface for target volume definition, offering a dynamic and adaptable solution for treatment planning. This will enable the unprecedented opportunity to process both scientific publications and patient-specific data to generate literature-founded, personalized, and precise target volumes.

The project has three main objectives: (1) curating an extensive and high-quality multicenter CT dataset, (2) developing and fine-tuning a multimodal foundation AI model for personalized target volume creation, and (3) clinically validating the framework across multiple centers using prospective clinical data, ensuring robust results in real-world settings.

By integrating cutting-edge AI technology with clinical expertise, AI-PIONEER will bridge the gaps between efficiency, standardization, and personalization in cancer treatment, ultimately improving patient outcomes worldwide. Thorough clinical validation will provide the basis for clinical translation. This approach is poised to significantly reduce the burden on clinicians while elevating the quality of cancer care.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-STG

See all projects funded under this call

Host institution

KLINIKUM DER TECHNISCHEN UNIVERSITÄT MÜNCHEN (TUM KLINIKUM)
Net EU contribution
€ 1 832 292,00
Address
ISMANINGER STRASSE 22
81675 Muenchen
Germany
Region
Bayern Oberbayern München, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 832 292,00

Beneficiaries (1)